Home > Insider Trading > Filing (0000200406-13-000087)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
200406	Johnson & Johnson	JNJ	Pharmaceutical Preparations (2834)	221024240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1385325	J Dominic Caruso	Johnson &Amp; Johnson One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933	Vp, Finance; Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-18	30,000	$53.93	83,534	No	4	M	Direct
Common Stock	Disposition	2013-07-18	30,000	$90.31	53,534	No	4	S	Direct
Common Stock	Acquisiton	2013-06-30	5	$0.00	64	No	4	J	Indirect	Johnson & Johnson Stock Fund in the 401(k) plan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	J	Indirect	Johnson & Johnson Stock Fund in the 401(k) plan

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (Right to Buy)	Disposition	2013-07-18	30,000	$0.00	30,000	$53.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2007-02-09	2014-02-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	225	Indirect	ESOP in the 401(k) plan

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Deferred Share Units	$0.00			0	12,081	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	0	12,081	Direct

Footnotes

Includes 96 shares held under Issuer's Dividend Reinvestment Plan.
This transaction was executed in multiple trades at prices ranging from $90.06 to $90.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide unpon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2013).
Shares held by ESOP under the Johnson & Johnson Savings Plan as of Plan's most recent reporting date (6/30/2013).
Awarded under Issuer's Stock Option Plan and exercisable in full starting one day after the third anniversary of the grant.
The Deferred Share Units held under the Issuer's Executive Income Deferral Plan are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).